Literature DB >> 6753910

Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.

K Silberbauer, B Stanek, H Templ.   

Abstract

1 A study was carried out to investigate the possible contribution of prostaglandins in captopril-induced hypotension. 2 Healthy volunteers and patients with essential hypertension were given single oral doses of 25 mg and 50 mg captopril respectively before and after cyclo-oxygenase inhibition with indomethacin. 3 The acute hypotensive effect of captopril was not associated with changes in heart rate. As expected, captopril led to an increase in plasma renin activity, decrease in plasma angiotensin II, and decrease in plasma aldosterone concentration. 4 After acute indomethacin pretreatment the acute hypotensive effect of captopril was significantly blunted in volunteers and in the 14 hypertensive patients. Changes in plasma renin activity and angiotensin II were significantly lower from a lower baseline. 5 Prostaglandins may therefore be mediators of the initial captopril effect. The blunting effect of indomethacin should be taken into account under clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753910      PMCID: PMC1427516          DOI: 10.1111/j.1365-2125.1982.tb02063.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  Determination of plasma angiotensin-II concentration: reliability of a practical method for clinical purposes. R.A.A.-system during furosemide administration.

Authors:  H Küppers; K Wiesen; E Schnurr
Journal:  Clin Chim Acta       Date:  1976-09-20       Impact factor: 3.786

3.  Renal prostaglandins: possible regulators of the renal actions of pressor hormones.

Authors:  J C McGiff; K Crowshaw; N A Terragno; A J Lonigro
Journal:  Nature       Date:  1970-09-19       Impact factor: 49.962

4.  Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats.

Authors:  M J Antonaccio; L Kerwin
Journal:  Eur J Pharmacol       Date:  1980-11-21       Impact factor: 4.432

5.  Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man.

Authors:  P Negus; R L Tannen; M J Dunn
Journal:  Prostaglandins       Date:  1976-08

6.  Actions of prostacyclin (PGI2) on adrenergic neuroeffector transmission in the rabbit kidney.

Authors:  P Hedqvist
Journal:  Prostaglandins       Date:  1979-02

7.  Tumor promoting phorbol diesters stimulate release of radioactivity from [3H]-arachidonic acid labeled- but not [14C]linoleic acid labeled-cells. Indomethacin inhibits the stimulated release from [3H] arachidonate labeled cells.

Authors:  K Ohuchi; L Levine
Journal:  Prostaglandins Med       Date:  1978-12

Review 8.  Prostaglandins, kinins and the regulation of blood pressure.

Authors:  J C McGiff; J Quilley
Journal:  Clin Exp Hypertens       Date:  1980       Impact factor: 1.749

9.  Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.

Authors:  K Abe; T Itoh; Y Imai; M Sato; T Haruyama; Y Sakurai; T Goto; Y Otsuka; K Yoshinaga
Journal:  Jpn Circ J       Date:  1980-05

10.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

Authors:  S L Swartz; G H Williams; N K Hollenberg; L Levine; R G Dluhy; T J Moore
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  9 in total

Review 1.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

3.  Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.

Authors:  A F Lant
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

Review 4.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 5.  The kinin system in hypertensive pathophysiology.

Authors:  Jagdish N Sharma
Journal:  Inflammopharmacology       Date:  2012-04-17       Impact factor: 4.473

Review 6.  Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Authors:  Y W Lam; A M Shepherd
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 7.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

8.  Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis.

Authors:  J R Lowe; J S Dixon; J A Guthrie; P McWhinney
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

9.  Identification and Functional Mechanism of Novel Angiotensin I Converting Enzyme Inhibitory Dipeptides from Xerocomus badius Cultured in Shrimp Processing Waste Medium.

Authors:  Xiujun Gao; Xiqi Li; Peisheng Yan; Rui Sun; Guangfeng Kan; Ying Zhou
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.